Back to search

Effect of Ifetroban, a Thromboxane a2Receptor Antagonist, in Stroke-Prone Spontaneously Hypertensive Rats

Data up to Jan 2025

Published1996
Citations7
References30

Total Citations Per Year

Abstract

References (30)

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

Statistical Methods for Survival Data Analysis

1981 • 758 citations

Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects

1980 • 642 citations

Establishment of the strokeprone spontaneously hypertensive rat (SHR)

1972 • 606 citations

Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events

1991 • 525 citations

Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans.

1976 • 372 citations

Regional Myocardial Blood Flow in Lambs with Concentric Right Ventricular Hypertrophy

1974 • 255 citations

A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat Via Radio-telemetry

1991 • 251 citations

Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.

1992 • 210 citations

Genetic predisposition to stroke in spontaneously hypertensive rats

1976 • 169 citations

Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats.

1989 • 143 citations

Possible role of nutritional factors in the incidence of cerebral lesions in stroke-prone spontaneously hypertensive rats.

1984 • 114 citations

Telemetric Monitoring of Cardiovascular Parameters in Conscious Spontaneously Hypertensive Rats

1993 • 101 citations

Treatment of ischaemic stroke with prostacyclin.

1983 • 90 citations

Role of prostaglandin H2-thromboxane A2 in responses of cerebral arterioles during chronic hypertension

1992 • 64 citations

Role of prostanoids in renin-dependent and renin-independent hypertension.

1991 • 63 citations

Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.

1993 • 59 citations

Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension.

1988 • 52 citations

Dissociation of endothelial cell dysfunction and blood pressure in SHR

1995 • 42 citations

Thromboxane Receptor Antagonist BMS-180291, but Not Aspirin, Reduces the Severity of Pacing-Induced Ischemia in Dogs

1994 • 28 citations

Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats.

1988 • 26 citations

Thromboxane receptor antagonist BMS-180291: A new pre-clinical lead

1992 • 22 citations

Single studies and overview analyses: is aspirin of value in cerebral ischemia?

1987 • 21 citations

Antiplatelet activity of the long-acting thromboxane receptor antagonist BMS 180,291 in monkeys

1992 • 17 citations

Role of thromboxane A2 in the hypotensive effect of captopril in essential hypertension.

1988 • 16 citations

Thromboxane A2 receptor antagonism and synthase inhibition in essential hypertension.

1993 • 15 citations

The Effect of the Thromboxane A2/Prostaglandin Endoperoxide Receptor Antagonist SQ 30,741 on Myocardial Infarct Size and Blood Flow During Myocardial Ischemia and Reperfusion

1988 • 15 citations

Myocardial Salvage Efficacy of the Thromboxane Receptor Antagonist Ifetroban in Ferrets and Dogs

1994 • 10 citations

Effects of prostaglandin inhibitors on the onset of proteinuria and stroke in stroke-prone spontaneously hypertensive rats.

1981 • 8 citations

Ifetroban Sodium < USAN >

1994 • 6 citations

Cited By (0)

Loading...